NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

RHYTHM BIOSCIENCES LIMITED (RHY)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of RHY: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000RHY2
Address: Bio21 Molecular Science & Biotechnology Institute 30 Flemington Road Parkville, Vic, 3010
Tel:  +61 3 8256 2880

Date first listed: 07/12/2017

Sector: Health Care Equipment & Services 
Activities: Research, development and commercialisation of medical diagnostic technology

News & Events

Expand this box to read and print

The suspension of trading in the securities of Rhythm Biosciences Limited will be lifted immediately following the release by RHY of an announcement originally intended to lift the trading halt applied to RHY's securities on 1 March 2023.

06/03/2023

After receipt and analysis of a thorough application review and its most recent engagement with the Australian Therapeutic Goods Administratio, the Company has decided to withdraw its current ColoSTAT application for an Australian Register of Therapeutic Goods listing. The Company intends to submit a new ColoSTAT® application with the TGA, in line to better meet their feedback and questions posed. The new ColoSTAT application will be submitted at a date to be determined, however is expected to be in the current calendar year. This intended withdrawal does not impede the Company's proposed market entry activities into other CE Mark conforming territories and additional international markets, including the U.S.A.

06/03/2023

The securities of Rhythm Biosciences Limited will be suspended from quotation immediately under Listing Rule 17.3. The securities will remain suspended pending the release of an announcement originally intended to lift the trading halt applied to RHY's securities on 1 March 2023.

03/03/2023

listed entity carried for record purposes only

07/12/2017

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    12/05/2023Otto Buttula683,895$0.363$248,246
    08/09/2022Otto Buttula-5,000,000$1.300$6,498,570
    13/11/2018David White30,220$0.166$5,001

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Otto ButtulaNon Exec Chairman28/10/2019
    Sue MacLemanDeputy Chairman31/01/2023
    David AtkinsCEO13/05/2024
    Trevor LockettNon Exec Director07/12/2017
    Louis PanccioDirector07/12/2017
    Andrea SteeleCompany Secretary
    James BarrieCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Rachel DavidIndependent Director15/12/202128/12/2023
    Paul SmithCFO27/10/202215/11/2023
    Glenn GilbertManaging Director, CEO22/05/201821/04/2023
    Eduardo VomNon Exec Director05/06/202029/11/2022
    David WhiteDirector07/12/201715/07/2021
    Shane TannerChairman07/12/201725/10/2019

    Date of first appointment, title may have changed.